GLOW is a premixed vial of BPC-157, TB-500 and GHK-Cu, 70 mg in total, marketed for skin and recovery together. Mark and Amy look at what is actually known. No study has tested the blend itself, so the case for it is borrowed from each ingredient's separate evidence.
What we covered
- What GLOW is: a premixed vial of three peptides, 70 mg in total.
- The mechanism as described: BPC-157 supports local repair and blood-vessel growth, TB-500 helps cells move to injured tissue, and GHK-Cu delivers copper and drives collagen signaling. How they act together has not been studied.
- The evidence rating: 2 out of 5. No studies of the blend. BPC-157 and TB-500 are mostly animal data, and GHK-Cu's human data is topical.
- Skin firmness and collagen: small human studies of GHK-Cu showed improved skin, but they were topical.
- Tissue repair: BPC-157 and TB-500 sped healing in animal injury models.
- Skin glow and recovery: self-reported only.
- Status: not FDA-approved, and banned by WADA.
- Half-life: mixed, since each component differs, but all are short-acting signals.
- Calculator arithmetic: a 70 mg vial with 3.5 mL of water is 20 mg/mL, and 2000 mcg is 10 units on a U-100 syringe. This is arithmetic only, not a recommendation.
Sources
Free tools
- Peptide calculator: https://www.mypeps.info/calculator
Mark and Amy are AI-generated voices; every episode is reviewed by our editor, Ryan E., MS. Educational information, not medical advice.